Skip to main content

Table 2 Predictors of COPD exacerbations

From: Variability of antibiotic prescribing in patients with chronic obstructive pulmonary disease exacerbations: a cohort study

Characteristic

Exacerbation Cases

Controls

Unadjusted matched

 

12,609 (%)

35,299 (%)

OR (95% CI)

Age at exacerbation

   

 40–49

340 (2.7%)

985 (2.8%)

 

 50–59

1,473 (11.7%)

4,120 (11.7%)

 

 60–69

3,548 (28.1%)

9,831 (27.9%)

 

 70–79

4,399 (34.9%)

12,210 (34.6%)

 

 80+

2,849 (22.6%)

8,153 (23.1%)

 

Male

6,240 (49.5%)

17,604 (49.9%)

 

Quintile of Index of Multiple Deprivation

   

 0 (least deprived)

1,358 (10.8%)

4,564 (12.9%)

0.81 (0.75–0.87)

 1

2,033 (16.1%)

5,964 (16.9%)

0.92 (0.86–0.99)

 2

2,585 (20.5%)

7,022 (19.9%)

1.00

 3

2,659 (21.1%)

7,479 (21.2%)

0.97 (0.91–1.03)

 4 (most deprived)

3,974 (31.5%)

10,270 (29.1%)

1.05 (0.99–1.11)

Body mass index at exacerbation

   

 Underweight

1,562 (12.4%)

3,795 (10.8%)

1.13 (1.06–1.21)

 Normal

3,846 (30.5%)

10,610 (30.1%)

1.00

 Overweight

3,747 (29.7%)

10,747 (30.4%)

0.96 (0.91–1.01)

 Obese

2,856 (22.7%)

8,295 (23.5%)

0.95 (0.90–1.01)

 Unknown

598 (4.7%)

1,852 (5.2%)

0.89 (0.81–0.99)

Smoking status at exacerbation

   

 Non Smoker

840 (6.7%)

3,171 (9.0%)

1.00

 Ex Smoker

7,141 (56.6%)

19,618 (55.6%)

1.38 (1.27–1.50)

 Smoker

4,600 (36.5%)

12,414 (35.2%)

1.42 (1.30–1.55)

 Unknown

28 (0.2%)

96 (0.3%)

1.12 (0.73–1.72)

Prescriptions in the previous three months

   

 Antibiotics

6,403 (50.8%)

12,193 (34.5%)

1.95 (1.87–2.03)

 Oral glucocorticoid therapies

4,270 (33.9%)

5,871 (16.6%)

2.57 (2.45–2.69)

 Anticholinergics

8,092 (64.2%)

16,738 (47.4%)

1.99 (1.91–2.08)

Medical history

   

 Hypertension

5,216 (41.4%)

15,163 (43.0%)

0.93 (0.89–0.97)

 Diabetes

2,047 (16.2%)

6,028 (17.1%)

0.94 (0.89–0.99)

 Heart Failure

1,314 (10.4%)

3,476 (9.8%)

1.07 (1.00–1.15)

 Depression

4,624 (36.7%)

11,717 (33.2%)

1.17 (1.12–1.22)

Forced expiratory volume in one second (FEV1) as proportion of predicted

   

 Mild COPD (≥80)

1,832 (14.5%)

6,102 (17.3%)

1.00

 Moderate COPD (50–<80%)

4,245 (33.7%)

13,838 (39.2%)

1.03 (0.96–1.09)

 Severe COPD (30–<50%)

3,625 (28.7%)

7,533 (21.3%)

1.61 (1.51–1.72)

 Very severe COPD (<30%)

1,362 (10.8%)

2,146 (6.1%)

2.12 (1.95–2.32)

 Unknown

1,545 (12.3%)

5,680 (16.1%)

0.88 (0.82–0.96)